Home>
US Stocks>
X T L Biopharmaceuticals

X T L Biopharmaceuticals share price today

(XTLB)

X T L Biopharmaceuticals share price is $1.88 & ₹160.17 as on 25 Dec 2024, 2.30 'hrs' IST

$1.88

▲

0.12

(6.82%)

Market is closed - opens 8 PM, 26 Dec 2024

View live X T L Biopharmaceuticals share price in Dollar and Rupees. Guide to invest in X T L Biopharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in X T L Biopharmaceuticals. Get details on the Indian mutual funds that are investing in X T L Biopharmaceuticals. Get Analyst recommendations and forecasts along with all the X T L Biopharmaceuticals's financials.

X T L Biopharmaceuticals share price movements

Today's Low: $1.57
Today's High: $1.88
$1.88
16.46%
Downside
Day's Volatility :16.46%
Upside
0.0%
52 Weeks Low: $0.77
52 Weeks High: $4.99
$1.88
59.14%
Downside
52 Weeks Volatility :84.61%
Upside
62.32%

X T L Biopharmaceuticals Returns

Period	X T L Biopharmaceuticals Ltd	Index (Russel 2000)
3 Months	-25.69%	0.0%
6 Months	-16.44%	0.0%
1 Year	88.0%	0.0%
3 Years	-30.11%	-21.1%

X T L Biopharmaceuticals Key Statistics

in dollars & INR

Previous Close	$1.76
Open	$1.72
Today's High	$1.88
Today's Low	$1.5705
Market Capitalization	$9.6M
Today's Volume	$1.1K
52 Week High	$4.9897
52 Week Low	$0.7681
Revenue TTM	$0.0
EBITDA	$-764.0K
Earnings Per Share (EPS)	$-0.03
Profit Margin	0.0%
Quarterly Earnings Growth YOY	-0.76%
Return On Equity TTM	-13.07%

How to invest in X T L Biopharmaceuticals from India?

It is very easy for Indian residents to invest directly in X T L Biopharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the X T L Biopharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for X T L Biopharmaceuticals or XTLB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of X T L Biopharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of X T L Biopharmaceuticals shares which would translate to 0.453 fractional shares of X T L Biopharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like X T L Biopharmaceuticals, in just a few clicks!

Returns in X T L Biopharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

X T L Biopharmaceuticals investment value today

Current value as on today

₹1,90,426

Returns

₹90,426

(+90.43%)

Returns from X T L Biopharmaceuticals Stock

₹88,000 (+88%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards X T L Biopharmaceuticals

-56%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for X T L Biopharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -56% less investors are searching X T L Biopharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in X T L Biopharmaceuticals

Noked Israel Ltd
3.65%
Morgan Stanley - Brokerage Accounts
0.49%
Rhumbline Advisers
0.12%

Analyst Recommendation on X T L Biopharmaceuticals

Analyst Forecast on X T L Biopharmaceuticals

What analysts predicted

Upside of 1495.74%

Current:

$1.88

Target:

$30.00

Insights on X T L Biopharmaceuticals

Price Movement
In the last 7 days, XTLB stock has moved up by 25.8%
XTLB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 56.1%

X T L Biopharmaceuticals Technicals Summary

Sell

Neutral

Buy

X T L Biopharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

X T L Biopharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
X T L Biopharmaceuticals Ltd	0.0%	-16.44%	88.0%	-30.11%	28.95%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
X T L Biopharmaceuticals Ltd	NA	NA	0.0	0.0	-0.13	-0.14	NA	0.01
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
X T L Biopharmaceuticals Ltd	NA	$9.6M	28.95%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About X T L Biopharmaceuticals

xtl biopharmaceuticals ltd. (nasdaq:xtlb, tase:xtlb.ta) is a clinical-stage biotech company focused on the development of pharmaceutical products for the treatment of autoimmune diseases including lupus. the company’s lead drug candidate, hcdr1, is a world-class clinical asset for the treatment of systemic lupus erythematosus (sle). treatments currently on the market for sle are not effective enough for most patients and some have significant side effects. robust clinical data on hcdr1 has been produced in three clinical trials with 400 patients and over 200 preclinical studies with data published in more than 40 peer reviewed scientific journals.

Organization	X T L Biopharmaceuticals
Employees	0
CEO	Mr. Shlomo Spokone Shalev
Industry	Health Technology

Management People of X T L Biopharmaceuticals

Name	Title
Mr. Shlomo Spokone Shalev	CEO & Director
Mr. Itay Weinstein CPA	Chief Financial Officer

Important FAQs about investing in X T L Biopharmaceuticals from India :

What is X T L Biopharmaceuticals share price today?

X T L Biopharmaceuticals share price today stands at $1.88, Open: $1.72 ; Previous Close: $1.76 ; High: $1.88 ; Low: $1.57 ; 52 Week High: $4.99 ; 52 Week Low: $0.77. The stock opens at $1.72, after a previous close of $1.76. The stock reached a daily high of $1.88 and a low of $1.57, with a 52-week high of $4.99 and a 52-week low of $0.77.

Can Indians buy X T L Biopharmaceuticals shares?

Yes, Indians can invest in the X T L Biopharmaceuticals (XTLB) from India.

With INDmoney, you can buy X T L Biopharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy X T L Biopharmaceuticals at zero transaction cost.

How can I buy X T L Biopharmaceuticals shares from India?

It is very easy to buy X T L Biopharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of X T L Biopharmaceuticals be purchased?

Yes, you can buy fractional shares of X T L Biopharmaceuticals with INDmoney app.

What are the documents required to start investing in X T L Biopharmaceuticals stocks?

To start investing in X T L Biopharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.